RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAUEA84B67CC85749F7

https://w3id.org/ripe/ripe-kg/author/RIPEAUEA84B67CC85749F7
SubjectPredicateObject
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type node1
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type rdfs:Resource
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type owl:Thing
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type prov:Person
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type foaf:Person
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan owl:sameAs https://semopenalex.org/author/A5004028554
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan foaf:familyName Bazrafshan
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan foaf:givenName Amir
ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan foaf:name Amir Bazrafshan
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity dcterms:creator ripekg:author/RIPEAUEA84B67CC85749F7Amir Bazrafshan